Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate

doi 10.1021/acs.jmedchem.7b01466.s002

Full Text

Abstract

Available in

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR

English

A Novel, Highly Potent and Selective Phosphodiesterase-9 Inhibitor for the Treatment of Sickle Cell Disease

Haematologica
Hematology
2019English

The Brain-Penetrant Clinical ATM Inhibitor AZD1390 Radiosensitizes and Improves Survival of Preclinical Brain Tumor Models

Science advances
Multidisciplinary
2018English

A Brain-Penetrant MET Inhibitor Achieves Responses in Glioblastoma

Cancer Discovery
Oncology
2018English

Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor

English

Preclinical Characterization of Anlotinib, a Highly Potent and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor

Cancer Science
Cancer ResearchMedicineOncology
2018English

A Brain Penetrant Mutant IDH1 Inhibitor Provides in Vivo Survival Benefit

Scientific Reports
Multidisciplinary
2017Breton

Nonclinical and Clinical Pharmacological Characterization of the Potent and Selective Cathepsin K Inhibitor MIV-711

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

TAS4464, a Highly Potent and Selective Inhibitor of NEDD8 Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy